Dalacin C 150 Mg 150 mg Capsule
PDF Leaflet Revision Date: 17 January 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Serious infections caused by susceptible Gram-positive organisms and anaerobic pathogens.
Dosage (summary)
Adults: 150 mg every 6 hours for mild infections; up to 450 mg every 6 hours for severe infections.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors may reduce clearance
- Neuromuscular blocking agents
Contraindications
- Hypersensitivity to clindamycin
- Diarrhoeal states
- Gastrointestinal disease
Common side effects
- Diarrhoea
- Abdominal pain
- Eosinophilia
- Maculopapular rash
Counselling Points
- Take with a full glass of water
- Do not chew or crush capsules
- Report severe diarrhea immediately
Serious warnings
- Severe hypersensitivity reactions
- Risk of antibiotic-associated colitis
Important Disclaimer
The Dalacin C 150 Mg 150 mg Capsule professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
